Interlinked and Droplet IV awarded Eurostars grant for DropLink project

Interlinked AB and Droplet IV have been awarded a Eurostars grant for the collaborative DropLink project, supporting the development of new technology for safer, more efficient and more sustainable IV therapy.

The project brings together complementary technologies and expertise from Interlinked and Droplet IV with the aim of addressing challenges associated with IV therapy and fluid management.

Combining technologies to advance IV therapy

DropLink will explore the integration of Interlinked’s connector technology with Droplet IV’s approach to IV flushing, bringing together two innovations developed around improving the delivery and management of IV therapy.

The collaboration will focus on developing and evaluating the combined solution, with the broader ambition of supporting patient safety, efficient clinical workflows and more sustainable use of healthcare resources.

The Eurostars funding provides an important framework for the two companies to advance the project together and build the technical and clinical foundation for its continued development.

A new European collaboration

For Interlinked, the project represents another step in expanding the applications of its technology through collaboration with other healthcare innovators.

Working together with Droplet IV will enable both teams to combine their expertise, test the technology and explore how the integrated solution could address unmet needs in IV therapy.

Interlinked is grateful for the support from Eurostars and looks forward to working closely with the Droplet IV team as the DropLink project moves forward.

The project marks the beginning of a new collaboration focused on developing practical solutions for the future of IV therapy.